ESC Professional Premium Access

Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals of the general population with and without diabetes mellitus

Congress Presentation

About the speaker

Doctor Paul Michael Haller

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
0 follower

6 more presentations in this session

Remnant cholesterol contributes to residual lipid risk after acute coronary syndromes

Speaker: Doctor F. Wenzl (Zurich, CH)

Thumbnail

Prevalence of coronary atherosclerosis in individuals with pre-diabetes and diabetes compared to normoglycemic individuals

Speaker: Professor C. Ostgren (Linkoping, SE)

Thumbnail

Low-density lipoprotein cholesterol levels and long-term bleeding in patients undergoing percutaneous coronary intervention: 5-year outcomes from a large cohort study

Speaker: Doctor J. Li (Beijing, CN)

Thumbnail

Heme oxygenase-1 polymorphisms associate with ischemic cardiac complications and mortality in type 1 diabetes

Speaker: Doctor H. Segersvard (Helsinki, FI)

Thumbnail

Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and impaired glucose metabolism

Speaker: Doctor D. Sa (Funchal, PT)

Thumbnail

Access the full session

Coronary artery disease - Epidemiology, prognosis, outcome 5

Speakers: Doctor P. Haller, Doctor F. Wenzl, Professor C. Ostgren, Doctor J. Li, Doctor H. Segersvard...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations